Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0000919574-21-003782

Director bought 180,000 shares at an average $2.18 ($392,460)

From the SEC's structured data for this filing

Trades in this filing

ARMISTICE CAPITAL, LLC · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-14 Purchase : show line 1 in the form +128,000 $2.15 $275,200 39,048,000 D
2021-05-14 Purchase : show line 2 in the form +0 39,048,000 I
2021-05-17 Purchase : show line 3 in the form +30,000 $2.20 $66,000 39,078,000 D
2021-05-17 Purchase : show line 4 in the form +0 39,078,000 I
2021-05-18 Purchase : show line 5 in the form +22,000 $2.33 $51,260 39,100,000 D
2021-05-18 Purchase : show line 6 in the form +0 39,100,000 I
Open-market purchases · 180,000 sh · avg $2.18 · $392,460
Loading xslF345X03/ownership.xml…